Yingnan Wang

Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial

Feng Wang, Ying Jin, Min Wang et al. · Nature Medicine · 2024 · 165 citations

Medicine, Oncology, Pharmacology +14

Tumor mutational and indel burden: a systematic pan-cancer evaluation as prognostic biomarkers

Hao‐Xiang Wu, Zixian Wang, Qi Zhao et al. · Annals of Translational Medicine · 2019 · 133 citations · Full text

Medicine, Immunology, Oncology +17

Bone marrow-derived mesenchymal stem cell-secreted IL-8 promotes the angiogenesis and growth of colorectal cancer

Jiancheng Wang, Yingnan Wang, Shao‐Chuan Wang et al. · Oncotarget · 2015 · 91 citations · Full text

Medicine, Oncology, Surgery +13

p53-dependent CD51 expression contributes to characteristics of cancer stem cells in prostate cancer

Xin Sui, Jianye Cai, Hongyu Li et al. · Cell Death and Disease · 2018 · 32 citations · Full text

Medicine, Molecular Biology, Oncology +17

Elevated peripheral blood neutrophil-to-lymphocyte ratio is associated with an immunosuppressive tumour microenvironment and decreased benefit of PD-1 antibody in advanced gastric cancer

Dan‐Yun Ruan, Yan‐Xing Chen, Xiaoli Wei et al. · Gastroenterology report · 2021 · 28 citations · Full text

Medicine, Immunology, Oncology +17